{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:36:27Z","timestamp":1790685387928,"version":"4.1.0"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T00:00:00Z","timestamp":1591142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:sec>\n                <jats:title>Abstract<\/jats:title>\n                <jats:p>Thyroid cancer is the most common sort of endocrine-related cancer with more prevalent in women and elderly individuals which has quickly widespread expansion in worldwide over the recent decades. Common features of malignant thyroid cells are to have accelerated metabolism and increased glucose uptake to optimize their energy supply which provides a fundamental advantage for growth. In tumor cells the retaining of required energy charge for cell survival is imperative, indeed glucose transporters are enable of promoting of this task. According to this relation it has been reported the upregulation of glucose transporters in various types of cancers. Human studies indicated that poor survival can be occurred following the high levels of GLUT1 expression in tumors. GLUT-1 and GLUT3 are the glucose transporters which seems to be mainly engaged with the oncogenesis of thyroid cancer and their expression in malignant tissues is much more than in the normal one. They are promising targets for the advancement of anticancer strategies. The lack of oncosuppressors have dominant effect on the membrane expression of GLUT1 and glucose uptake. Overexpression of hypoxia inducible factors have been additionally connected with distant metastasis in thyroid cancers which mediates transcriptional regulation of glycolytic genes including GLUT1 and GLUT3. Though the physiological role of the thyroid gland is well illustrated, but the metabolic regulations in thyroid cancer remain evasive. In this study we discuss proliferation pathways of the key regulators and signaling molecules such as PI3K-Akt, HIF-1, MicroRNA, PTEN, AMPK, BRAF, c-Myc, TSH, Iodide and p53 which includes in the regulation of GLUTs in thyroid cancer cells. Incidence of deregulations in cellular energetics and metabolism are the most serious signs of cancers. In conclusion, understanding the mechanisms of glucose transportation in normal and pathologic thyroid tissues is critically important and could provide significant insights in science of diagnosis and treatment of thyroid disease.<\/jats:p>\n                \n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12964-020-00586-x","type":"journal-article","created":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T14:31:56Z","timestamp":1591194716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":75,"title":["Regulators of glucose uptake in thyroid cancer cell lines"],"prefix":"10.1186","volume":"18","author":[{"given":"Shabnam","family":"Heydarzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Asghar","family":"Moshtaghie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Daneshpoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5816-775X","authenticated-orcid":false,"given":"Mehdi","family":"Hedayati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,3]]},"reference":[{"key":"586_CR1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.metabol.2015.10.007","volume":"65","author":"CC Barron","year":"2016","unstructured":"Barron CC, Bilan PJ, Tsakiridis T, Tsiani E. Facilitative glucose transporters: implications for cancer detection, prognosis and treatment. Metabolism. 2016;65:124\u201339.","journal-title":"Metabolism"},{"key":"586_CR2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1152\/ajpendo.00407.2001","volume":"282","author":"HG Joost","year":"2002","unstructured":"Joost HG, Bell GI, Best JD, Birnbaum MJ, Charron MJ, Chen YT, Doege H, James DE, Lodish HF, Moley KH, Moley JF, Mueckler M, Rogers S, et al. Nomenclature of the GLUT\/SLC2A family of sugar\/polyol transport facilitators. Am J Physiol Endocrinol Metab. 2002;282:974\u20136.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"586_CR3","first-page":"164","volume":"2013","author":"L Szablewski","year":"1835","unstructured":"Szablewski L. Expression of glucose transporters in cancers. Biochim Biophys Acta. 1835;2013:164\u20139.","journal-title":"Biochim Biophys Acta"},{"key":"586_CR4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jcb.23379","volume":"113","author":"K Reinicke","year":"2012","unstructured":"Reinicke K, Sotomayor P, Cisterna P, Delgado C, Nualart F, Godoy A. Cellular distribution of Glut-1 and Glut-5 in benign and malignant human prostate tissue. J Cell Biochem. 2012;113:553\u201362.","journal-title":"J Cell Biochem"},{"key":"586_CR5","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1089\/thy.2004.14.806","volume":"14","author":"K Matsuzu","year":"2004","unstructured":"Matsuzu K, Segade F, Matsuzu U, Carter A, Bowden DW, Perrier ND. Differential expression of glucose transporters in normal and pathological thyroid tissue. Thyroid. 2004;14:806\u201312.","journal-title":"Thyroid"},{"key":"586_CR6","first-page":"59","volume":"54","author":"F Morani","year":"2012","unstructured":"Morani F, Pagano L, Prodam F, Aimaretti G, Isidoro C. Loss of expression of the oncosuppressor PTEN in associates with GLUT1 plasmamembrane expression. Panminerva Med. 2012;54:59\u201363.","journal-title":"Panminerva Med"},{"key":"586_CR7","first-page":"1151","volume":"2","author":"M Younes","year":"1996","unstructured":"Younes M, Lechago LV, Lechago J. Overexpression of the human erythrocyte glucose transporter occurs as a late event in human colorectal carcinogenesis and is associated with an increased incidence of lymph node metastasis. Clin Cancer Res. 1996;2:1151\u20134.","journal-title":"Clin Cancer Res"},{"key":"586_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/(SICI)1097-0142(19980701)83:1<34::AID-CNCR5>3.0.CO;2-E","volume":"83","author":"RS Haber","year":"1998","unstructured":"Haber RS, Rathan A, Weiser KR, Pritsker A, Itzkowitz SH, Bodian C, Slater G, Weiss A, Burstein DE. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998;83:34\u201340.","journal-title":"Cancer"},{"key":"586_CR9","doi-asserted-by":"crossref","first-page":"32748","DOI":"10.18632\/oncotarget.4977","volume":"6","author":"A Koch","year":"2015","unstructured":"Koch A, Lang SA, Wild PJ, Gantner S, Mahli A, Spanier G, Berneburg M, M\u00fcller M, Bosserhoff AK, Hellerbrand C. Glucose transporter isoform 1 espression enhance metastasis of malignant melanoma cells. Oncotarget. 2015;6:32748\u201360.","journal-title":"Oncotarget."},{"key":"586_CR10","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2353\/ajpath.2009.080596","volume":"174","author":"T Amann","year":"2009","unstructured":"Amann T, Maegdefrau U, Hartmann A, Agaimy A, Marienhagen J, Weiss TS, Stoeltzing O, Warnecke C, Sch\u00f6lmerich J, Oefner PJ, Kreutz M, Bosserhoff AK, Hellerbrand C. GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis. Am J Pathol. 2009;174:1544\u201352.","journal-title":"Am J Pathol"},{"key":"586_CR11","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1002\/1097-0142(19931115)72:10<2979::AID-CNCR2820721020>3.0.CO;2-X","volume":"72","author":"RS Brown","year":"1993","unstructured":"Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer. 1993;72:2979\u201385.","journal-title":"Cancer"},{"key":"586_CR12","first-page":"544","volume":"24","author":"P Ravazoula","year":"2003","unstructured":"Ravazoula P, Batistatou A, Aletra C, Ladopoulos J, Kourounis G, Tzigounis B. Immunoisotchemical expression of glucose transporter Glut1 and cyclin D1 in breast carcinomas with negative lymph nodes. Eur J Gynaecol Oncol. 2003;24:544\u20136.","journal-title":"Eur J Gynaecol Oncol"},{"key":"586_CR13","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/1097-0142(20010901)92:5<1144::AID-CNCR1432>3.0.CO;2-T","volume":"92","author":"G Cantuaria","year":"2001","unstructured":"Cantuaria G, Fagotti A, Ferrandina G, Magalhaes A, Nadji M, Angioli R, Penalver M, Mancuso S, Scambia G. GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy. Cancer. 2001;92:1144\u201350.","journal-title":"Cancer"},{"key":"586_CR14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2010.11.019","volume":"121","author":"A Semaan","year":"2011","unstructured":"Semaan A, Munkarah AR, Arabi H, Bandyopadhyay S, Seward S, Kumar S, Qazi A, Hussein Y, Morris RT, AliFehmi R. Expression of GLUT-1 in epithelial ovarian carcinoma: correlation with tumor cell proliferation, angiogenesis, survival and ability to predict optimal cytoreduction. Gynecol Oncol. 2011;121:181\u20136.","journal-title":"Gynecol Oncol"},{"issue":"82","key":"586_CR15","first-page":"1","volume":"8","author":"RG Coelho","year":"2018","unstructured":"Coelho RG, Fortunato RS, Carvalho DP. Metabolic reprogramming in thyroid carcinoma, thyroid Cancer and glycolysis. Front Oncol. 2018;8(82):1\u201315.","journal-title":"Front Oncol"},{"key":"586_CR16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2274","volume":"8","author":"CV Dang","year":"2008","unstructured":"Dang CV, Kim JW, Gao P, Yustein J. The interplay between MYC and HIF in cancer. Nat Rev Cancer. 2008;8:51\u20136.","journal-title":"Nat Rev Cancer"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1200\/JCO.2002.20.2.379","volume":"20","author":"R Bos","year":"2002","unstructured":"Bos R, van Der Hoeven JJ, van Der Wall E, van Der Groep P, van Diest PJ, Comans EF, Joshi U, Semenza GL, Hoekstra OS, Lammertsma AA, Molthoff CF. Biologic correlates of (18) fluorodeoxyglucose uptake in human breast cancer measured by positron emission tomography. J Clin Oncol. 2002;20:379\u201387.","journal-title":"J Clin Oncol"},{"key":"586_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/RLU.0b013e3182393599","volume":"37","author":"F Grabellus","year":"2012","unstructured":"Grabellus F, Nagarajah J, Bockisch A, Schmid KW, Sheu SY. Glucose transporter 1 expression, tumor proliferation, and iodine\/glucose uptake in thyroid cancer with emphasis on poorly differentiated thyroid carcinoma. Clin Nucl Med. 2012;37:121\u20137.","journal-title":"Clin Nucl Med"},{"key":"586_CR19","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1089\/105072502760339307","volume":"12","author":"J Sch\u00f6nberger","year":"2002","unstructured":"Sch\u00f6nberger J, Ru\u00f6schoff J, Grimm D, Marienhagen J, Ru\u00f6mmele P, Meyringer R, Kossmehl P, Hofstaedter F, Eilles C. Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study. Thyroid. 2002;12:747\u201354.","journal-title":"Thyroid"},{"key":"586_CR20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s40336-013-0025-z","volume":"1","author":"M Bongiovanni","year":"2013","unstructured":"Bongiovanni M, Paone G, Ceriani L, Pusztaszeri M. Cellular and molecular basis for thyroid cancer imaging in nuclear medicine. Clin Transl Imag. 2013;1:149\u201361.","journal-title":"Clin Transl Imag"},{"key":"586_CR21","unstructured":"Warburg O, Posener K, Negelein E, The metabolism of the carcinoma cell. In: the metabolism of tumors: Richard R. Smith, Inc; 1931. p. 129\u201369."},{"key":"586_CR22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","volume":"123","author":"O Warburg","year":"1956","unstructured":"Warburg O. On the origin of cancer cells. Science. 1956;123:309\u201314.","journal-title":"Science"},{"key":"586_CR23","first-page":"77","volume":"355","author":"M Hatanaka","year":"1974","unstructured":"Hatanaka M. Transport of sugars in tumor cell membranes. Biochim Biophys Acta. 1974;355:77\u2013104.","journal-title":"Biochim Biophys Acta"},{"key":"586_CR24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM197201062860111","volume":"286","author":"KJ Isselbacher","year":"1972","unstructured":"Isselbacher KJ. Sugar and amino acid transport by cells in culture\u2014differences between normal and malignant cells. N Engl J Med. 1972;286:929\u201333.","journal-title":"N Engl J Med"},{"key":"586_CR25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1073\/pnas.69.3.585","volume":"69","author":"KJ Isselbacher","year":"1972","unstructured":"Isselbacher KJ. Increased uptake of amino acids and 2- deoxy-d-glucose by virus-transformed cells in culture. Proc Natl Acad Sci U S A. 1972;69:585\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1260","key":"586_CR26","first-page":"1","volume":"19","author":"HY Suh","year":"2019","unstructured":"Suh HY, Choi H, Paeng JC, Cheon GJ, Chung JK, Kang KW. Comprehensive gene expression analysis for exploring the association between glucose metabolism and differentiation of thyroid cancer. BMC Cancer. 2019;19(1260):1\u20139.","journal-title":"BMC Cancer"},{"issue":"6","key":"586_CR27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1089\/thy.2005.15.545","volume":"15","author":"K Matsuzu","year":"2005","unstructured":"Matsuzu K, et al. Glucose transporters in the thyroid. Thyroid. 2005;15(6):545\u201350.","journal-title":"Thyroid"},{"key":"586_CR28","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2004-0779","volume":"90","author":"L Hooft","year":"2005","unstructured":"Hooft L, van der Veldt AA, van Diest PJ, Hoekstra OS, Berkhof J, Teule GJ, Molthoff CF. [18F] fluorodeoxyglucose uptake in recurrent thyroid cancer is related to hexokinase i expression in the primary tumor. J Clin Endocrinol Metab. 2005;90:328\u201334.","journal-title":"J Clin Endocrinol Metab"},{"issue":"32","key":"586_CR29","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.18632\/oncotarget.24684","volume":"10","author":"H Yang","year":"2019","unstructured":"Yang H, Zhong J-T, Zhou S-H, Han H-M. Roles of GLUT-1 and HK-II expression in the biological behavior of head and neck cancer. Oncotarget. 2019;10(32):3066\u201383.","journal-title":"Oncotarget"},{"key":"586_CR30","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3892\/mmr.2012.969","volume":"6","author":"P Jozwiak","year":"2012","unstructured":"Jozwiak P, Krzeslak A, Pomorski L, Lipinska A. Expression of hypoxia-related glucose transporters GLUT1 and GLUT3 in benign, malignant and non-neoplastic thyroid lesions. Mol Med Rep. 2012;6:601\u20136.","journal-title":"Mol Med Rep"},{"key":"586_CR31","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/endo.141.11.7793","volume":"141","author":"N Samih","year":"2000","unstructured":"Samih N, Hovsepian S, Aouani A, Lombardo D, Fayet G. Glut-1 translocation in FRTL-5 thyroid cells: role of phosphatidylinositol 3-kinase and N-glycosylation. Endocrinology. 2000;141:4146\u201355.","journal-title":"Endocrinology."},{"key":"586_CR32","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1089\/thy.2012.0041","volume":"22","author":"BM Andrade","year":"2012","unstructured":"Andrade BM, Cazarin J, Zancan P, Carvalho DP. AMP-activated protein kinase upregulates glucose uptake in thyroid PCCL3 cells independent of thyrotropin. Thyroid. 2012;22:1063\u20138.","journal-title":"Thyroid"},{"key":"586_CR33","first-page":"59","volume":"54","author":"F Morani","year":"2012","unstructured":"Morani F, Pagano L, Prodam F, Aimaretti G, Isidoro C. Loss of expression of the oncosuppressor PTEN in thyroid incidentalomas associates with GLUT1 plasmamembrane expression. Panminerva Med. 2012;54:59\u201363.","journal-title":"Panminerva Med"},{"issue":"3","key":"586_CR34","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","volume":"13","author":"M Xing","year":"2013","unstructured":"Xing M. Molecular pathogenesis and mechanisms of thyroid cancer. Nat Rev Cancer. 2013;13(3):184\u201399.","journal-title":"Nat Rev Cancer"},{"key":"586_CR35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000104457","volume":"53","author":"RE Airley","year":"2007","unstructured":"Airley RE, Mobasheri A. Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics. Chemotherapy. 2007;53:233\u201356.","journal-title":"Chemotherapy."},{"key":"586_CR36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pharmthera.2008.09.005","volume":"121","author":"V Ganapathy","year":"2009","unstructured":"Ganapathy V, Thangaraju M, Prasad PD. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond. Pharmacol Ther. 2009;121:29\u201340.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"586_CR37","doi-asserted-by":"crossref","first-page":"37","DOI":"10.5528\/wjtm.v3.i2.37","volume":"3","author":"Y Qian","year":"2014","unstructured":"Qian Y, Wang X, Chen X. Inhibitors of glucose transport and glycolysis as novel anticancer therapeutics. World J Transl Med. 2014;3(2):37\u201357.","journal-title":"World J Transl Med"},{"key":"586_CR38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","volume":"7","author":"RJ DeBerardinis","year":"2008","unstructured":"DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008;7:11\u201320.","journal-title":"Cell Metab"},{"key":"586_CR39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1126\/science.1211485","volume":"334","author":"D Anastasiou","year":"2011","unstructured":"Anastasiou D, Poulogiannis G, Asara JM, Boxer MB, Jiang JK, Shen M, Bellinger G, Sasaki AT, Locasale JW, Auld DS, Thomas CJ, Vander Heiden MG, Cantley LC. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science. 2011;334:1278\u201383.","journal-title":"Science"},{"key":"586_CR40","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ng.890","volume":"43","author":"JW Locasale","year":"2011","unstructured":"Locasale JW, Grassian AR, Melman T, Lyssiotis CA, Mattaini KR, Bass AJ, Heffron G, Metallo CM, Muranen T, Sharf H, Sasaki AT, Anastasiou D, Mullarky E, Vokes NI, Sasaki M, Beroukhim R, Stephanopoulos G, Ligon AH, Meyerson M, Richardson AL, Chin L, Wagner G, Asara JM, Brugge JS, Cantley LC, Vander Heiden MG. Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis. Nat Genet. 2011;43:869\u201374.","journal-title":"Nat Genet"},{"key":"586_CR41","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.cell.2008.08.021","volume":"134","author":"PP Hsu","year":"2008","unstructured":"Hsu PP, Sabatini DM. Cancer cell metabolism: Warburg and beyond. Cell. 2008;134:703\u20137.","journal-title":"Cell"},{"key":"586_CR42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11:85\u201395.","journal-title":"Nat Rev Cancer"},{"key":"586_CR43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","volume":"13","author":"G Kroemer","year":"2008","unstructured":"Kroemer G, Pouyssegur J. Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel. Cancer Cell. 2008;13:472\u201382.","journal-title":"Cancer Cell"},{"key":"586_CR44","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1126\/science.312.5777.1158","volume":"312","author":"K Garber","year":"2006","unstructured":"Garber K. Energy deregulation: licensing tumors to grow. Science. 2006;312:1158\u20139.","journal-title":"Science."},{"key":"586_CR45","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","volume":"4","author":"RA Gatenby","year":"2004","unstructured":"Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nat Rev Cancer. 2004;4:891\u20139.","journal-title":"Nat Rev Cancer"},{"key":"586_CR46","doi-asserted-by":"crossref","first-page":"8927","DOI":"10.1158\/0008-5472.CAN-06-1501","volume":"66","author":"JW Kim","year":"2006","unstructured":"Kim JW, Dang CV. Cancer\u2019s molecular sweet tooth and the Warburg effect. Cancer Res. 2006;66:8927\u201330.","journal-title":"Cancer Res"},{"key":"586_CR47","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1158\/1535-7163.MCT-12-0131","volume":"11","author":"Y Liu","year":"2012","unstructured":"Liu Y, Cao Y, Zhang W, Bergmeier S, Qian Y, Akbar H, Colvin R, Ding J, Tong L, Wu S, Hines J, Chen X. A smallmolecule inhibitor of glucose transporter 1 downregulates glycolysis, induces cell-cycle arrest, and inhibits cancer cell growth in vitro and in vivo. Mol Cancer Ther. 2012;11:1672\u201382.","journal-title":"Mol Cancer Ther"},{"key":"586_CR48","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1111\/febs.14577","volume":"285","author":"P-B Ancey","year":"2018","unstructured":"Ancey P-B, Contat C, Meylan E. Glucose transporters in cancer-from tumor cells to the tumor microenvironment. FEBS J. 2018;285:2926\u201343.","journal-title":"FEBS J"},{"issue":"4","key":"586_CR49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/ERC-13-0088","volume":"20","author":"K Pak","year":"2013","unstructured":"Pak K, Kim SJ, Kim IJ, Kim BH, Kim SS, Jeon YK. The role of 18F-fluorodeoxyglucose positron emission tomography in differentiated thyroid cancer before surgery. Endocr Relat Cancer. 2013;20(4):203\u201313.","journal-title":"Endocr Relat Cancer"},{"key":"586_CR50","doi-asserted-by":"crossref","unstructured":"Wimmer I, Pichler R. FDG PET in thyroid cancer. Thyroid Cancer - Advances in Diagnosis and Therapy. 2016. Chapter 6 p. 127\u201335.","DOI":"10.5772\/64110"},{"key":"586_CR51","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2967\/jnumed.109.062331","volume":"50","author":"O Prante","year":"2009","unstructured":"Prante O, Maschauer S, Fremont V, Reinfelder J, Stoehr R, Szkudlinski M, et al. Regulation of uptake of 18F-FDG by a follicular human thyroid cancer cell line with mutation-activated K-Ras. J Nucl Med. 2009;50:1364\u201370.","journal-title":"J Nucl Med"},{"key":"586_CR52","doi-asserted-by":"crossref","first-page":"9052","DOI":"10.1073\/pnas.94.17.9052","volume":"94","author":"MP Myers","year":"1997","unstructured":"Myers MP, Stolarov JP, Eng C, Li J, Wang SI, Wigler MH, Parsons R, Tonks NK. P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1997;94:9052\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"51","key":"586_CR53","doi-asserted-by":"crossref","first-page":"84999","DOI":"10.18632\/oncotarget.13113","volume":"7","author":"S Phadngam","year":"2016","unstructured":"Phadngam S, Castiglioni A, Ferraresi A, Morani F, Follo C, Isidoro C. PTEN dephosphorylates AKT to prevent the expression of GLUT1 on plasmamembrane and to limit glucose consumption in cancer cells. Oncotarget. 2016;7(51):84999\u20135020.","journal-title":"Oncotarget"},{"issue":"1","key":"586_CR54","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40291-017-0303-y","volume":"22","author":"M Zarkesh","year":"2018","unstructured":"Zarkesh M, Zadeh-Vakili A, Azizi F, Foroughi F, Akhavan MM, Hedayati M. Altered epigenetic mechanisms in thyroid Cancer subtypes. Mol Diag Ther. 2018;22(1):41\u201356.","journal-title":"Mol Diag Ther"},{"issue":"3","key":"586_CR55","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12020-017-1368-4","volume":"57","author":"SA Razavi","year":"2017","unstructured":"Razavi SA, Modarressi MH, Yaghmaei P, Tavangar SM, Hedayati M. Circulating levels of PTEN and KLLN in papillary thyroid carcinoma: can they be considered as novel diagnostic biomarkers? Endocrine. 2017;57(3):428\u201335.","journal-title":"Endocrine."},{"key":"586_CR56","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.celrep.2017.10.053","volume":"21","author":"SR Shinde","year":"2017","unstructured":"Shinde SR, Maddika S. PTEN regulates glucose transporter recycling by impairing SNX27 Retromer assembly. Cell Rep. 2017;21:1655\u201366.","journal-title":"Cell Rep"},{"issue":"2","key":"586_CR57","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/JME-14-0118","volume":"53","author":"F Morani","year":"2014","unstructured":"Morani F, Phadngam S, Follo C, Titone R, Aimaretti G, Galetto A, Alabiso O, Isidoro C. PTEN regulates plasma membrane expression of glucose transporter 1and glucose uptake in thyroid cancer cells. J Mol Endocrinol. 2014;53(2):247\u201358.","journal-title":"J Mol Endocrinol"},{"key":"586_CR58","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/JME-14-0118","volume":"53","author":"F Morani","year":"2014","unstructured":"Morani F, Phadngam S, Follo C, Titone R, Aimaretti G, Galetto A, Alabiso O, Isidoro C. PTEN regulates plasma membrane expression of glucose transporter 1 and glucose uptake in thyroid cancer cells. J Mol Endocrinol. 2014;53:247\u201358.","journal-title":"J Mol Endocrinol"},{"key":"586_CR59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.cell.2012.02.030","volume":"149","author":"I Garcia-Cao","year":"2012","unstructured":"Garcia-Cao I, Song MS, Hobbs RM, Laurent G, Giorgi C, de Boer VC, Anastasiou D, Ito K, Sasaki AT, Rameh L, Carracedo A, Vander Heiden MG, Cantley LC, et al. Systemic elevation of PTEN induces a tumor-suppressive metabolic state. Cell. 2012;149:49\u201362.","journal-title":"Cell"},{"issue":"1","key":"586_CR60","first-page":"1045","volume":"3","author":"H Katoh","year":"2015","unstructured":"Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann Clin Pathol. 2015;3(1):1045.","journal-title":"Ann Clin Pathol"},{"issue":"1","key":"586_CR61","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1186\/s12885-018-5112-0","volume":"18","author":"M Zarkesh","year":"2018","unstructured":"Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Fanaei SA, Hedayati M, Azizi F. The role of matrix metalloproteinase-9 as a prognostic biomarker in papillary thyroid cancer. BMC Cancer. 2018 Dec 3;18(1):1199.","journal-title":"BMC Cancer"},{"key":"586_CR62","first-page":"1","volume":"1325","author":"L Manzella","year":"2017","unstructured":"Manzella L, et al. New insights in thyroid cancer and P53 familly proteins. Int J Mol Sci. 2017;1325:1\u201315.","journal-title":"Int J Mol Sci"},{"key":"586_CR63","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1002\/cncr.21073","volume":"103","author":"RM Quiros","year":"2005","unstructured":"Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations. Cancer. 2005;103:2261\u20138.","journal-title":"Cancer"},{"key":"586_CR64","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1530\/eje.0.1340177","volume":"134","author":"D Salvatore","year":"1996","unstructured":"Salvatore D, Celetti A, Fabien N, Paulin C, Martelli ML, Battaglia C, Califano D, Monaco C, Viglietto G, Santoro M, et al. Low frequency of p53 mutations in human thyroid tumours; p53 and Ras mutation in two out of fifty-six thyroid tumours. Eur J Endocrinol. 1996;134:177\u201383.","journal-title":"Eur J Endocrinol"},{"key":"586_CR65","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Integrated genomic characterization of papillary thyroid carcinoma. Cell. 2014;159:676\u201390.","journal-title":"Cell"},{"key":"586_CR66","doi-asserted-by":"crossref","first-page":"15077","DOI":"10.1038\/nrdp.2015.77","volume":"1","author":"H Dralle","year":"2015","unstructured":"Dralle H, Machens A, Basa J, Fatourechi V, Franceschi S, Hay ID, Nikiforov YE, Pacini F, Pasieka JL, Sherman SI. Follicular cell-derived thyroid cancer. Nat Rev Dis Primers. 2015;1:15077.","journal-title":"Nat Rev Dis Primers"},{"key":"586_CR67","first-page":"617","volume":"18","author":"CR Berkers","year":"2013","unstructured":"Berkers CR, Maddocks OD, Cheung EC, Mor I, Vousden KH. Metabolic regulation by p53 family members. CellMetab. 2013;18:617\u201333.","journal-title":"CellMetab."},{"key":"586_CR68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ceb.2009.12.001","volume":"22","author":"MC Maiuri","year":"2010","unstructured":"Maiuri MC, Galluzzi L, Morselli E, Kepp O, Malik SA, Kroemer G. Autophagy regulation by p53. Curr Opin Cell Biol. 2010;22:181\u20135.","journal-title":"Curr Opin Cell Biol"},{"key":"586_CR69","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.cell.2009.11.026","volume":"139","author":"PA Muller","year":"2009","unstructured":"Muller PA, Caswell PT, Doyle B, et al. Mutant p53 drives invasion by promoting integrin recycling. Cell. 2009;139:1327\u201341.","journal-title":"Cell."},{"key":"586_CR70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","volume":"107","author":"JP Morton","year":"2010","unstructured":"Morton JP, Timpson P, Karim SA, et al. Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer. Proc Natl Acad Sci U S A. 2010;107:246\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7\u20138","key":"586_CR71","doi-asserted-by":"crossref","first-page":"226","DOI":"10.18632\/genesandcancer.21","volume":"5","author":"F Morani","year":"2014","unstructured":"Morani F, Phadngam S, Follo C, Titone R, Thongrakard V, Galetto A, Alabiso O, Isidoro C. PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. Genes Cancer. 2014;5(7\u20138):226\u201336.","journal-title":"Genes Cancer"},{"key":"586_CR72","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1158\/0008-5472.CAN-03-0846","volume":"64","author":"F Schwartzenberg-Bar-Yoseph","year":"2004","unstructured":"Schwartzenberg-Bar-Yoseph F, Armoni M, Karnieli E. The tumor suppressor p53 Down-regulates glucose transporters GLUT1 and GLUT4 gene expression. The American journal of Cancer. Cancer Res. 2004;64:2627\u201333.","journal-title":"Cancer Res"},{"key":"586_CR73","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/diacare.13.3.198","volume":"13","author":"GI Bell","year":"1990","unstructured":"Bell GI, Kayano T, Buse JB, Burant CF, Takeda J, Lin D, et al. Molecular biology of mammalian glucose transporters. Diabetes Care. 1990;13:198\u2013208.","journal-title":"Diabetes Care"},{"issue":"1","key":"586_CR74","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1756-6614-4-S1-S1","volume":"4","author":"J Braun","year":"2011","unstructured":"Braun J, H\u00fcttelmaier S. Pathogenic mechanisms of deregulated microRNA expression in thyroid carcinomas of follicular origin. Thyroid Res. 2011;4(1):S1.","journal-title":"Thyroid Res"},{"key":"586_CR75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ydbio.2006.08.028","volume":"302","author":"B Zhang","year":"2007","unstructured":"Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol. 2007;302:1\u201312.","journal-title":"Dev Biol"},{"key":"586_CR76","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.3892\/mmr.2016.5477","volume":"14","author":"K YUE","year":"2016","unstructured":"YUE K, WANG X, Y WU, X ZHOU, Q HE, Y DUAN. microRNA-7 regulates cell growth, migration and invasion via direct targeting of PAK1 in thyroid cancer. Mol Med Rep. 2016;14:2127\u201334.","journal-title":"Mol Med Rep"},{"key":"586_CR77","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(03)00428-8","volume":"113","author":"V Ambros","year":"2003","unstructured":"Ambros V. MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell. 2003;113:673\u20136.","journal-title":"Cell."},{"key":"586_CR78","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.18632\/oncotarget.16681","volume":"9","author":"T Wang","year":"2018","unstructured":"Wang T, Xu H, Qi M, et al. miRNA dysregulation and the risk of metastasis and invasion in papillary thyroid cancer: a systematic review and meta-analysis. Oncotarget. 2018;9:5473\u20139.","journal-title":"Oncotarget."},{"key":"586_CR79","doi-asserted-by":"crossref","unstructured":"Perdas E, Stawski R, Nowak D, et al. Potential of liquid biopsy in papillary thyroid carcinoma in context of miRNA, BRAF and p53 mutation. Curr Drug Targets. 2018.","DOI":"10.2174\/1389450119666180226124349"},{"issue":"19","key":"586_CR80","first-page":"30198","volume":"S0024\u20133205","author":"M Zarkesh","year":"2019","unstructured":"Zarkesh M, Zadeh-Vakili A, Akbarzadeh M, Nozhat Z, Fanaei SA, Hedayati M, Azizi F. BRAF V600E mutation and microRNAs are helpful in distinguishing papillary thyroid malignant lesions: Tissues and fine needle aspiration cytology cases. Life Sci. 2019;S0024\u20133205(19):30198\u20135.","journal-title":"Life Sci"},{"key":"586_CR81","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/978-3-319-42118-6_3","volume":"207","author":"EC Lien","year":"2016","unstructured":"Lien EC, Lyssiotis CA, Cantley LC. Metabolic reprogramming by the PI3K-AktmTOR pathway in Cancer. Recent Results Cancer Res. 2016;207:39\u201372.","journal-title":"Recent Results Cancer Res"},{"key":"586_CR82","first-page":"7","volume":"211","author":"X Wang","year":"2018","unstructured":"Wang X, Qi M. miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1. Pathol Res Pract. 2018;211:7.","journal-title":"Pathol Res Pract"},{"key":"586_CR83","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/JME-13-0266","volume":"52","author":"MS Dettmer","year":"2014","unstructured":"Dettmer MS, Perren A, Moch H, Komminoth P, Nikiforov YE, Nikiforova MN. MicroRNA profile of poorly differentiated thyroid carcinomas: new diagnostic and prognostic insights. J Mol Endocrinol. 2014;52:181\u20139.","journal-title":"J Mol Endocrinol"},{"key":"586_CR84","first-page":"1","volume":"0","author":"P Huang","year":"2018","unstructured":"Huang P, Mao L, Zhang Z, Lv W, Feng X, Liao H, Dong CH, Kaluba B, Tang X, Chang SH. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer. Thyroid. 2018;0:1\u201311.","journal-title":"Thyroid"},{"issue":"4","key":"586_CR85","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1210\/endo-118-4-1395","volume":"118","author":"S Filetti","year":"1986","unstructured":"Filetti S, Vetri M, Damante G, Belfiore A. Thyroid autoregulation: effect of iodine on glucose transport in cultured thyroid cells. Endocrinology. 1986;118(4):1395\u2013400.","journal-title":"Endocrinology."},{"key":"586_CR86","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M. BRAF mutation in thyroid cancer. Endocr Relat Cancer. 2005;12:245\u201362.","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"586_CR87","doi-asserted-by":"crossref","first-page":"662","DOI":"10.2967\/jnumed.114.150607","volume":"56","author":"J Nagarajah","year":"2015","unstructured":"Nagarajah J, et al. Correlation of BRAFV600E mutation and glucose metabolism in thyroid Cancer patients: an 18F-FDG PET study. J Nucl Med. 2015;56(5):662\u20137.","journal-title":"J Nucl Med"},{"issue":"4","key":"586_CR88","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/thy.2011.0401","volume":"22","author":"F Grabellus","year":"2012","unstructured":"Grabellus F, et al. The BRAF V600E mutation in papillary thyroid carcinoma is associated with glucose transporter 1 overexpression. Thyroid. 2012;22(4):377\u201382.","journal-title":"Thyroid."},{"key":"586_CR89","doi-asserted-by":"crossref","unstructured":"Leonardi G. C., and et al. BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (review). 2012; 6(4): 687\u2013694.","DOI":"10.3892\/mmr.2012.1016"},{"issue":"24","key":"586_CR90","doi-asserted-by":"crossref","first-page":"7511","DOI":"10.1158\/1078-0432.CCR-11-1155","volume":"17","author":"LM Caronia","year":"2011","unstructured":"Caronia LM, Phay JE, Shah MH. Role of BRAF in thyroid oncogenesis. Clin Cancer Res. 2011;17(24):7511\u20137.","journal-title":"Clin Cancer Res"},{"key":"586_CR91","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1677\/ERC-08-0251","volume":"17","author":"N Burrows","year":"2010","unstructured":"Burrows N, Resch J, Cowen RL, Wasielewski R, Hoang-Vu C, West CM, Williams KJ, Brabant G. Expression of hypoxia-inducible factor 1\u03b1 in thyroid carcinomas. Endocr Relat Cancer. 2010;17:61\u201372.","journal-title":"Endocr Relat Cancer"},{"key":"586_CR92","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nature04871","volume":"441","author":"J Pouyssegur","year":"2006","unstructured":"Pouyssegur J, Dayan F, Mazure NM. Hypoxia signaling in cancer and approaches to enforce tumour regression. Nature. 2006;441:437\u201343.","journal-title":"Nature."},{"key":"586_CR93","doi-asserted-by":"crossref","unstructured":"Ciavardelli D, Bellomo M, Consalvo A, Crescimanno C, Vella V. Metabolic alteration of thyroid cancer as potential therapeutic targets. Biomed Res Int. 2011:1\u201310.","DOI":"10.1155\/2017\/2545031"},{"key":"586_CR94","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2174\/138955709788922610","volume":"9","author":"A Marin-Hern\u00e1ndez","year":"2009","unstructured":"Marin-Hern\u00e1ndez A, Gallardo-P\u00e8rez JC, Ralph SJ, Rodr\u00edguez-Enr\u00edquez S, Moreno-S\u00e1nchez R. HIF-1 alpha modulates energy metabolism in cancer by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 2009;9:1084\u2013101.","journal-title":"Mini Rev Med Chem"},{"key":"586_CR95","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.redox.2017.04.018","volume":"12","author":"B Kalyanaraman","year":"2017","unstructured":"Kalyanaraman B. Teaching the basics of cancer metabolism: developing antitumor strategies by exploiting the differences between normal and cancer cell metabolism. Redox Biol. 2017;12:833\u201342.","journal-title":"Redox Biol"},{"issue":"2","key":"586_CR96","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40199-018-0208-2","volume":"26","author":"Z Nozhat","year":"2018","unstructured":"Nozhat Z, Mohammadi-Yeganeh S, Azizi F, Zarkesh M, Hedayati M. Effects of metformin on the PI3K\/AKT\/FOXO1 pathway in anaplastic thyroid Cancer cell lines. Daru. 2018;26(2):93\u2013103.","journal-title":"Daru."},{"key":"586_CR97","first-page":"1","volume":"2","author":"A Klaus","year":"2017","unstructured":"Klaus A, Fathi O, Tatjana TW, Bruno N, Oskar K. Expression of hypoxiaassociated protein HIF 1\u03b1 in follicular thyroid cancer is associated with distant metastasis. Pathol Oncol Res. 2017;2:1\u20138.","journal-title":"Pathol Oncol Res"},{"key":"586_CR98","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721\u201332.","journal-title":"Nat Rev Cancer"},{"key":"586_CR99","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrc2468","volume":"8","author":"NC Denko","year":"2008","unstructured":"Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8:705\u201313.","journal-title":"Nat Rev Cancer"},{"key":"586_CR100","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","volume":"20","author":"KK Wong","year":"2010","unstructured":"Wong KK, Engelman JA, Cantley LC. Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev. 2010;20:87\u201390.","journal-title":"Curr Opin Genet Dev"},{"issue":"188","key":"586_CR101","first-page":"1","volume":"6","author":"H Robbins","year":"2016","unstructured":"Robbins H, Hague A. The PI3K\/Akt pathway in tumors of endocrine tissues. Front Endocrinol. 2016;6(188):1\u201322.","journal-title":"Front Endocrinol"},{"key":"586_CR102","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","volume":"129","author":"BD Manning","year":"2007","unstructured":"Manning BD, Cantley LC. AKT\/PKB signaling: navigating downstream. Cell. 2007;129:1261\u201374.","journal-title":"Cell"},{"key":"586_CR103","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.274.29.20281","volume":"274","author":"A Barthel","year":"1999","unstructured":"Barthel A, Okino ST, Liao J, Nakatani K, Li J, Whitlock JP Jr, et al. Regulation of GLUT1 gene transcription by the serine\/threonine kinase Akt1. J Biol Chem. 1999;274:20281\u20136.","journal-title":"J Biol Chem"},{"issue":"17","key":"586_CR104","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1200\/JCO.2003.10.130","volume":"21","author":"G Garcia-Rostan","year":"2003","unstructured":"Garcia-Rostan G, Zhao H, Camp RL, Pollan M, Herrero A, Pardo J, et al. Ras mutations are associated with aggressive tumor phenotypes and poor prognosis in thyroid cancer. J Clin Oncol. 2003;21(17):3226\u201335.","journal-title":"J Clin Oncol"},{"key":"586_CR105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/nature04869","volume":"441","author":"RJ Shaw","year":"2006","unstructured":"Shaw RJ, Cantley LC. Ras, PI (3) K and mTOR signalling controls tumor cell growth. Nature. 2006;441:424\u201330.","journal-title":"Nature"},{"issue":"21","key":"586_CR106","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1093\/nar\/gku1075","volume":"43","author":"SA Forbes","year":"2015","unstructured":"Forbes SA, Beare D, Gunasekaren P, Leung K, Bindal N, Boutselakis H, et al. COSMIC: exploring the world\u2019s knowledge of somatic mutations in human cancer. Nucl Acids Res. 2015;43(21):805\u201311.","journal-title":"Nucl Acids Res"},{"issue":"1","key":"586_CR107","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40291-015-0175-y","volume":"20","author":"Z Nozhat","year":"2016","unstructured":"Nozhat Z, Hedayati M. PI3K\/AKT pathway and its mediators in thyroid carcinomas. Mol Diagn Ther. 2016;20(1):13\u201326.","journal-title":"Mol Diagn Ther"},{"issue":"4","key":"586_CR108","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14740\/jocmr2480w","volume":"8","author":"S Shan Jin","year":"2016","unstructured":"Shan Jin S, Borkhuu O, Bao W, Yang Y. Signaling pathways in thyroid cancer and their therapeutic implications. J Clin Med Res. 2016;8(4):284\u201396.","journal-title":"J Clin Med Res"},{"issue":"6","key":"586_CR109","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.3892\/ijmm.2015.2368","volume":"36","author":"M Chen","year":"2015","unstructured":"Chen M, Shen M, Li Y, et al. GC-MS-based metabolomics analysis of human papillary thyroid carcinoma tissue. Int J Mol Med. 2015;36(6):1607\u201314.","journal-title":"Int J Mol Med"},{"issue":"4","key":"586_CR110","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00259-003-1401-0","volume":"31","author":"JT Deichen","year":"2004","unstructured":"Deichen JT, Schmidt C, Prante O, Maschauer S, Papadopoulos T, Kuwert T. Influence of TSH on uptake of [18F] fluorodeoxyglucose in human thyroid cells in vitro. Eur J Nucl Med Mol Imaging. 2004;31(4):507\u201312.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"12","key":"586_CR111","first-page":"1989","volume":"41","author":"F Moog","year":"2000","unstructured":"Moog F, et al. Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma. J Nuclear Med. 2000;41(12):1989\u201395.","journal-title":"J Nuclear Med"},{"key":"586_CR112","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0303-7207(91)90018-N","volume":"82","author":"G Brabant","year":"1991","unstructured":"Brabant G, Maenhaut C, Kohrle J, Scheumann G, Dralle H, Hoang-Vu C, Hesch RD, von zur Muhlen A, Vassart G, Dumont JE. Human thyrotropin receptor gene: expression in thyroid tumors and correlation to markers of thyroid differentiation and dedifferentiation. Mol Cell Endocrinol. 1991;82:7\u201312.","journal-title":"Mol Cell Endocrinol"},{"issue":"114","key":"586_CR113","first-page":"1","volume":"8","author":"HS Sabnis","year":"2017","unstructured":"Sabnis HS, Somasagara RR, Bunting KD. Targeting MYC dependence by metabolic inhibitors in Cancer. Genes. 2017;8(114):1\u201320.","journal-title":"Genes."},{"key":"586_CR114","doi-asserted-by":"crossref","first-page":"7381","DOI":"10.1128\/MCB.00440-07","volume":"27","author":"JW Kim","year":"2007","unstructured":"Kim JW, Gao P, Liu YC, Semenza GL, Dang CV. Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1. Mol Cell Biol. 2007;27:7381\u201393.","journal-title":"Mol Cell Biol"},{"key":"586_CR115","doi-asserted-by":"crossref","first-page":"5923","DOI":"10.1128\/MCB.24.13.5923-5936.2004","volume":"24","author":"JW Kim","year":"2004","unstructured":"Kim JW, Zeller KI, Wang Y, et al. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol Cell Biol. 2004;24:5923\u201336.","journal-title":"Mol Cell Biol"},{"issue":"21","key":"586_CR116","doi-asserted-by":"crossref","first-page":"6479","DOI":"10.1158\/1078-0432.CCR-09-0889","volume":"15","author":"CV Dang","year":"2009","unstructured":"Dang CV, Le A, Gao P. MYC-induced Cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res. 2009;15(21):6479\u201383.","journal-title":"Clin Cancer Res"},{"key":"586_CR117","doi-asserted-by":"crossref","first-page":"21797","DOI":"10.1074\/jbc.C000023200","volume":"275","author":"RC Osthus","year":"2000","unstructured":"Osthus RC, Shim H, Kim S, et al. Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. J Biol Chem. 2000;275:21797\u2013800.","journal-title":"J Biol Chem"},{"key":"586_CR118","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/0006-291X(91)91540-S","volume":"174","author":"K Ohta","year":"1991","unstructured":"Ohta K, Endo T, Onaya T. The mRNA levels of thyrotropin receptor, thyroglobulin and thyroid peroxidase in neoplastic human thyroid tissues. Biochem Biophys Res Commun. 1991;174:1148\u201353.","journal-title":"Biochem Biophys Res Commun"},{"key":"586_CR119","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbamcr.2013.01.025","volume":"1833","author":"CA Wu","year":"2013","unstructured":"Wu CA, Chao Y, Shiah SG, Lin WW. Nutrient deprivation induces the Warburg effect through ROS\/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochim Biophys Acta. 2013;1833:1147\u201356.","journal-title":"Biochim Biophys Acta"},{"key":"586_CR120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1089\/thy.2015.0440","volume":"26","author":"JM Cazarin","year":"2016","unstructured":"Cazarin JM, Coelho RG, Hecht F, Andrade BM, Carvalho DP. 5\u2032-AMPactivated protein kinase regulates papillary (TPC1 and BCPAP) thyroid cancer cell survival, migration, invasion and epithelial-to-mesenchymal transition. Thyroid. 2016;26:933\u201342.","journal-title":"Thyroid"},{"key":"586_CR121","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2217\/fon.09.174","volume":"6","author":"Z Luo","year":"2010","unstructured":"Luo Z, Zang M, Guo W. AMPK as a metabolic tumor suppressor: control of metabolism and cell growth. Future Oncol. 2010;6:457\u201370.","journal-title":"Future Oncol"},{"key":"586_CR122","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cmet.2012.12.001","volume":"17","author":"B Faubert","year":"2013","unstructured":"Faubert B, Boily G, Izreig S, Griss T, Samborska B, Dong Z, et al. AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo. Cell Metab. 2013;17:113\u201324.","journal-title":"Cell Metab"},{"key":"586_CR123","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/EJE-13-0284","volume":"169","author":"AP Vidal","year":"2013","unstructured":"Vidal AP, Andrade BM, Vaisman F, Cazarin J, Pinto LF, Breitenbach MM, et al. AMP-activated protein kinase signaling is upregulated in papillary thyroid cancer. Eur J Endocrinol. 2013;169:521\u20138.","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"586_CR124","first-page":"133","volume":"19","author":"Z Nozhat","year":"2017","unstructured":"Nozhat Z, Hedayati M, Azizi F. Metabolomics and thyroid cancers: new approaches for biomarkers discovery. Iran J Endocrinol Metab. 2017;19(3):133\u201343.","journal-title":"Iran J Endocrinol Metab"},{"key":"586_CR125","doi-asserted-by":"crossref","unstructured":"Nozhat Z, Hedayati M, Azizi F. Thyroid cancer epidemic: A peril or an alarm? Int J Endocrinology Metab. 2015; 13(4).","DOI":"10.5812\/ijem.28491"},{"key":"586_CR126","doi-asserted-by":"crossref","unstructured":"Burrows N, Babur M, Resch J, Williams KJ, Brabant G. Hypoxia-inducible factor in thyroid carcinoma. J Thyroid Res. 2011:1\u201317.","DOI":"10.4061\/2011\/762905"},{"key":"586_CR127","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/jcp.20166","volume":"202","author":"ML Macheda","year":"2005","unstructured":"Macheda ML, Rogers S, Best JD. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol. 2005;202:654\u201362.","journal-title":"J Cell Physiol"},{"key":"586_CR128","doi-asserted-by":"crossref","unstructured":"Calvo MB, Figueroa A, Pulido EG, Campelo RG, Aparicio LA. Potential role of sugar transporters in cancer and their relationship with anticancer therapy. Int J Endocrinol. 2010:1\u201314.","DOI":"10.1155\/2010\/205357"},{"issue":"125","key":"586_CR129","first-page":"154","volume":"25","author":"Z Nozhat","year":"2015","unstructured":"Nozhat Z, Azizi F, Hedayati M. A review on molecular biomarkers of thyroid carcinoma. J Mazandaran University Med Sci. 2015;25(125):154\u201370.","journal-title":"J Mazandaran University Med Sci"},{"key":"586_CR130","doi-asserted-by":"crossref","first-page":"4915","DOI":"10.1016\/j.bmcl.2014.09.041","volume":"24","author":"C Granchi","year":"2014","unstructured":"Granchi C, Fancelli D, Minutolo F. An update on therapeutic opportunities offered by cancer glycolytic metabolism. Bioorg Med Chem Lett. 2014;24:4915\u201325.","journal-title":"Bioorg Med Chem Lett"}],"updated-by":[{"DOI":"10.1186\/s12964-022-00826-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T00:00:00Z","timestamp":1643068800000}}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00586-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-020-00586-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-020-00586-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,25]],"date-time":"2022-01-25T15:12:16Z","timestamp":1643123536000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-020-00586-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,3]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s12964-020-00586-x","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12964-022-00826-2","asserted-by":"object"}]},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,3]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12964-022-00826-2","URL":"https:\/\/doi.org\/10.1186\/s12964-022-00826-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This is not applicable for this review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This is not applicable for this review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}